ReP USP - Resultado da busca

Trabalho de evento-resumo periodico
Dysregulated activating and inhibitory receptors on natural killer cells predicts immune escape and poor outcomes in acute myeloid leukemia (2022)
Costa, Amanda Fernandes de Oliveira ; Kuznetsova, Valeriya; Marani, Leticia Olops ; Lopes, Izabela Aparecida; Binelli, Larissa S; Scheucher, Priscila Santos ; Schiavinato, Josiane Lilian dos Santos ; Faria, Joana Teresa Bisinella de ; Madeira, Maria Isabel A; Pagnano, Katia B; Duarte, Bruno K; Gloria, Ana Beatriz F; Rego, Eduardo Magalhães ; Traina, Fabiola ; Welner, Robert; Figueiredo-Pontes, Lorena Lobo
Source: Blood. Conference titles: ASH Annual Meeting. Unidades: FMRP, FM
Subjects: LEUCEMIA MIELOIDE AGUDA, FISIOPATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, Amanda Fernandes de Oliveira et al. Dysregulated activating and inhibitory receptors on natural killer cells predicts immune escape and poor outcomes in acute myeloid leukemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-168178. Acesso em: 27 jan. 2026. , 2022
APA
Costa, A. F. de O., Kuznetsova, V., Marani, L. O., Lopes, I. A., Binelli, L. S., Scheucher, P. S., et al. (2022). Dysregulated activating and inhibitory receptors on natural killer cells predicts immune escape and poor outcomes in acute myeloid leukemia. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-168178
NLM
Costa AF de O, Kuznetsova V, Marani LO, Lopes IA, Binelli LS, Scheucher PS, Schiavinato JL dos S, Faria JTB de, Madeira MIA, Pagnano KB, Duarte BK, Gloria ABF, Rego EM, Traina F, Welner R, Figueiredo-Pontes LL. Dysregulated activating and inhibitory receptors on natural killer cells predicts immune escape and poor outcomes in acute myeloid leukemia [Internet]. Blood. 2022 ; 140 9113-9114.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2022-168178
Vancouver
Costa AF de O, Kuznetsova V, Marani LO, Lopes IA, Binelli LS, Scheucher PS, Schiavinato JL dos S, Faria JTB de, Madeira MIA, Pagnano KB, Duarte BK, Gloria ABF, Rego EM, Traina F, Welner R, Figueiredo-Pontes LL. Dysregulated activating and inhibitory receptors on natural killer cells predicts immune escape and poor outcomes in acute myeloid leukemia [Internet]. Blood. 2022 ; 140 9113-9114.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2022-168178
Trabalho de evento-resumo periodico
Early donor T-Cell engraftment is critical for immune tolerance in reduced intensity haploidentical bone marrow transplant with post-transplant cyclophosphamide for sickle cell disease: vanderbilt global haploidentical transplant learning collaborative (2022)
Connelly, Jim A.; Biltibo, Eden; Wilkerson, Karina; Seber, Adriana; Gouveia, Roseane V; Bonfim, Carmem; Simões, Belinda Pinto ; Nur, Erfan; Horn, Biljana N.; Eckrich, Michael
Source: Blood. Conference titles: ASH Annual Meeting. Unidade: FMRP
Subjects: TRANSPLANTE DE MEDULA ÓSSEA, CÉLULAS, GENÉTICA, HEREDITARIEDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONNELLY, Jim A. et al. Early donor T-Cell engraftment is critical for immune tolerance in reduced intensity haploidentical bone marrow transplant with post-transplant cyclophosphamide for sickle cell disease: vanderbilt global haploidentical transplant learning collaborative. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2022-170552. Acesso em: 27 jan. 2026. , 2022
APA
Connelly, J. A., Biltibo, E., Wilkerson, K., Seber, A., Gouveia, R. V., Bonfim, C., et al. (2022). Early donor T-Cell engraftment is critical for immune tolerance in reduced intensity haploidentical bone marrow transplant with post-transplant cyclophosphamide for sickle cell disease: vanderbilt global haploidentical transplant learning collaborative. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2022-170552
NLM
Connelly JA, Biltibo E, Wilkerson K, Seber A, Gouveia RV, Bonfim C, Simões BP, Nur E, Horn BN, Eckrich M. Early donor T-Cell engraftment is critical for immune tolerance in reduced intensity haploidentical bone marrow transplant with post-transplant cyclophosphamide for sickle cell disease: vanderbilt global haploidentical transplant learning collaborative [Internet]. Blood. 2022 ; 140 10462-10464.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2022-170552
Vancouver
Connelly JA, Biltibo E, Wilkerson K, Seber A, Gouveia RV, Bonfim C, Simões BP, Nur E, Horn BN, Eckrich M. Early donor T-Cell engraftment is critical for immune tolerance in reduced intensity haploidentical bone marrow transplant with post-transplant cyclophosphamide for sickle cell disease: vanderbilt global haploidentical transplant learning collaborative [Internet]. Blood. 2022 ; 140 10462-10464.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2022-170552
Trabalho de evento-resumo periodico
Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo (2021)
Simões, Luíse Araújo de Albuquerque ; Weinhäuser, Isabel ; Martins, Diego Antonio Pereira ; Rojas, César Alexander Ortiz ; Bianco, Thiago Mantello ; Cavaglieri, Rita de Cássia ; Rego, Eduardo Magalhães
Source: Blood. Conference titles: ASH Annual Meeting. Unidades: FM, FMRP
Subjects: PROTEÍNAS, LEUCEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SIMÕES, Luíse Araújo de Albuquerque et al. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151069. Acesso em: 27 jan. 2026. , 2021
APA
Simões, L. A. de A., Weinhäuser, I., Martins, D. A. P., Rojas, C. A. O., Bianco, T. M., Cavaglieri, R. de C., & Rego, E. M. (2021). Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo. Blood. Washington: Faculdade de Medicina, Universidade de São Paulo. doi:10.1182/blood-2021-151069
NLM
Simões LA de A, Weinhäuser I, Martins DAP, Rojas CAO, Bianco TM, Cavaglieri R de C, Rego EM. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo [Internet]. Blood. 2021 ; 138 2368.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151069
Vancouver
Simões LA de A, Weinhäuser I, Martins DAP, Rojas CAO, Bianco TM, Cavaglieri R de C, Rego EM. Treatment with the recombinant SLIT2 protein delays AML leukemogenesis in vivo [Internet]. Blood. 2021 ; 138 2368.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151069
Trabalho de evento-resumo periodico
Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients (2021)
Campos, Paula de Melo; Pagnano, Katia B.; Mancuso, Rubia Isler; Della Via, Fernanda Isabel; Tinoco, Ângela Condotta; Mendonça, Guilherme Rossi Assis ; Freitas, Leandro Luiz Lopes; Traina, Fabiola ; Saad, Sara T. Olalla
Source: Blood. Conference titles: ASH Annual Meeting. Unidade: FMRP
Subjects: DOENÇAS INFECCIOSAS, FEBRE, DENGUE, ESTUDOS SOROEPIDEMIOLÓGICOS, RESÍDUOS SÓLIDOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CAMPOS, Paula de Melo et al. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151077. Acesso em: 27 jan. 2026. , 2021
APA
Campos, P. de M., Pagnano, K. B., Mancuso, R. I., Della Via, F. I., Tinoco, Â. C., Mendonça, G. R. A., et al. (2021). Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151077
NLM
Campos P de M, Pagnano KB, Mancuso RI, Della Via FI, Tinoco ÂC, Mendonça GRA, Freitas LLL, Traina F, Saad STO. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients [Internet]. Blood. 2021 ; 138 2584-2585.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151077
Vancouver
Campos P de M, Pagnano KB, Mancuso RI, Della Via FI, Tinoco ÂC, Mendonça GRA, Freitas LLL, Traina F, Saad STO. Final results of the fibromet trial: an open label phase II study to evaluate metformin effects on bone marrow fibrosis and disease progression in primary myelofibrosis patients [Internet]. Blood. 2021 ; 138 2584-2585.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151077
Trabalho de evento-resumo periodico
Genomic-based machine learning towards prediction of the etiology of bone marrow failure syndromes (2021)
Gutierrez-Rodrigues, Fernanda; Munger, Eric; Ma, Xiaoyang; Tang, Youbao; Groarke, Emma M.; Patel, Bhavisha A.; Catto, Luiz Fernando Bazzo ; Clé, Diego Villa ; Niewisch, Marena R.; Donaires, Flávia Sacilotto ; Kajigaya, Sachiko; Dunbar, Cynthia E.; Giri , Neelam; Oliveira , Michel Michels De; McReynolds, Lisa J.; Alter , Blanche P.; Savage, Sharon A.; Bonfim, Carmem M. S.; Wu, Colin O.; Calado, Rodrigo Tocantins ; Young, Neal S.
Source: Blood. Conference titles: ASH Annual Meeting. Unidade: FMRP
Subjects: GENÉTICA, MEDULA ÓSSEA, GENÔMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUTIERREZ-RODRIGUES, Fernanda et al. Genomic-based machine learning towards prediction of the etiology of bone marrow failure syndromes. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-151258. Acesso em: 27 jan. 2026. , 2021
APA
Gutierrez-Rodrigues, F., Munger, E., Ma, X., Tang, Y., Groarke, E. M., Patel, B. A., et al. (2021). Genomic-based machine learning towards prediction of the etiology of bone marrow failure syndromes. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-151258
NLM
Gutierrez-Rodrigues F, Munger E, Ma X, Tang Y, Groarke EM, Patel BA, Catto LFB, Clé DV, Niewisch MR, Donaires FS, Kajigaya S, Dunbar CE, Giri N, Oliveira MMD, McReynolds LJ, Alter BP, Savage SA, Bonfim CMS, Wu CO, Calado RT, Young NS. Genomic-based machine learning towards prediction of the etiology of bone marrow failure syndromes [Internet]. Blood. 2021 ; 138 2182-2183.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151258
Vancouver
Gutierrez-Rodrigues F, Munger E, Ma X, Tang Y, Groarke EM, Patel BA, Catto LFB, Clé DV, Niewisch MR, Donaires FS, Kajigaya S, Dunbar CE, Giri N, Oliveira MMD, McReynolds LJ, Alter BP, Savage SA, Bonfim CMS, Wu CO, Calado RT, Young NS. Genomic-based machine learning towards prediction of the etiology of bone marrow failure syndromes [Internet]. Blood. 2021 ; 138 2182-2183.[citado 2026 jan. 27 ] Available from: https://doi.org/10.1182/blood-2021-151258

USP Schools

ReP

Filtros

Authors

USP affiliated authors

Subjects

Non normalized affiliation